Nurs5334 Pharmacology Practice Exam With Answers (153 Solved Questions)
Sharpen your exam skills with Nurs5334 Pharmacology Practice Exam With Answers, a valuable resource featuring past tests.
Logan King
Contributor
4.1
40
4 months ago
Preview (7 of 20)
Sign in to access the full document!
Nurs 5334 Exam 3
1. Drugs for Gestational
Diabetes
Metformin and Insulin
2. A1C Value for Diabetes
Mellitus
6.5% or greater is diabetes, 5.7-6.4% pre-diabetes
3. Fasting and Random
Values for DM
Fasting plasma glucose—126 or greater is dia-
betes. Random plasma glucose—anything greater
than 200 is diabetes
4. Complications of In-
sulin Therapy
Hypoglycemia, Lipohypertrophy, Allergic reac-
tions, Desensitization procedure, Hypokalemia
5. Insulin Drug Interac-
tions
Hypoglycemic agents intensify hypoglycemia, Use
with caution with hyperglycemic agents
6. Beta Blockers' Effect
on Insulin
Delay awareness of hypoglycemia, Impair
glycogenolysis, Prevent counter-regulatory re-
sponse
7. Other Therapeutic Uses Hyperkalemia, Diagnosis of GH deficiency, Diabet-
ic ketoacidosis
8. Coordinating Insulin
Dosage
Carbohydrate intake
9. Blood Pressure Goal in
Diabetes
Controlled within normal 120/80
10. Medication for Diabetic
Nephropathy Risk
ACE inhibitor or ARB
11. Role of Exercise in DM
Treatment
Exercise increases cellular responsiveness to in-
sulin and glucose tolerance. 150 minutes per week
of moderate intensity exercise is recommended.
12. 4-Step Approach Steps Step 1: Diagnosis and lifestyle changes plus met-
formin. Step 2: Lifestyle changes, metformin, and
a second drug. Step 3: Three drug combination.
Step 4: Complex insulin regimen if needed.
1 / 20
1. Drugs for Gestational
Diabetes
Metformin and Insulin
2. A1C Value for Diabetes
Mellitus
6.5% or greater is diabetes, 5.7-6.4% pre-diabetes
3. Fasting and Random
Values for DM
Fasting plasma glucose—126 or greater is dia-
betes. Random plasma glucose—anything greater
than 200 is diabetes
4. Complications of In-
sulin Therapy
Hypoglycemia, Lipohypertrophy, Allergic reac-
tions, Desensitization procedure, Hypokalemia
5. Insulin Drug Interac-
tions
Hypoglycemic agents intensify hypoglycemia, Use
with caution with hyperglycemic agents
6. Beta Blockers' Effect
on Insulin
Delay awareness of hypoglycemia, Impair
glycogenolysis, Prevent counter-regulatory re-
sponse
7. Other Therapeutic Uses Hyperkalemia, Diagnosis of GH deficiency, Diabet-
ic ketoacidosis
8. Coordinating Insulin
Dosage
Carbohydrate intake
9. Blood Pressure Goal in
Diabetes
Controlled within normal 120/80
10. Medication for Diabetic
Nephropathy Risk
ACE inhibitor or ARB
11. Role of Exercise in DM
Treatment
Exercise increases cellular responsiveness to in-
sulin and glucose tolerance. 150 minutes per week
of moderate intensity exercise is recommended.
12. 4-Step Approach Steps Step 1: Diagnosis and lifestyle changes plus met-
formin. Step 2: Lifestyle changes, metformin, and
a second drug. Step 3: Three drug combination.
Step 4: Complex insulin regimen if needed.
1 / 20
13. Insulin Therapy Blood
Glucose Goals
Before meals: 70-130. Bedtime: 100-140.
14. A1C Goal and Excep-
tions
A1C goal is 7% or below. Exceptions: Severe hy-
poglycemia risk, limited life expectancy, advanced
complications.
15. Types of Insulins Short acting: Rapid acting insulins. Intermediate:
NPH insulin, insulin detemir. Long acting: Insulin
glargine.
16. Use of Short Duration
Insulins
Administered with meals to control post-prandial
blood glucose rise.
17. Need for Intermediate
Insulins
Administered 2-3 times daily for glycemic control
between meals and at night.
18. Duration of Insulins Glargine: Up to 24 hours. Levemir: 12-24 hours.
Degludec: Up to 42 hours.
19. Routes of Insulin Ad-
ministration
Subcutaneous injection and IV infusion. Inhalation:
Afrezza for mealtime insulin.
20. Insulin Dosing for Type
1 and Type 2
Type 1: Initial doses 0.5-0.6 units/kg/day. Type 2:
Initial doses 0.2-0.6 units/kg/day, adjusted based
on carb intake and activity.
21. 3 Dosing Schedules o Twice daily dosing
o Intensive basal/bolus strategy
o Continued subcutaneous insulin
22. Metformin Mechanism
of Action
o Inhibits glucose production in the liver
o Reduces glucose absorption in the gut
o Sensitizes insulin receptors in target tissues (fat
and skeletal muscle) to increase glucose uptake
and response to insulin
23. Metformin Side Effects
and BB Warning
o GI effects—diarrhea
o Lactic acidosis
2 / 20
Glucose Goals
Before meals: 70-130. Bedtime: 100-140.
14. A1C Goal and Excep-
tions
A1C goal is 7% or below. Exceptions: Severe hy-
poglycemia risk, limited life expectancy, advanced
complications.
15. Types of Insulins Short acting: Rapid acting insulins. Intermediate:
NPH insulin, insulin detemir. Long acting: Insulin
glargine.
16. Use of Short Duration
Insulins
Administered with meals to control post-prandial
blood glucose rise.
17. Need for Intermediate
Insulins
Administered 2-3 times daily for glycemic control
between meals and at night.
18. Duration of Insulins Glargine: Up to 24 hours. Levemir: 12-24 hours.
Degludec: Up to 42 hours.
19. Routes of Insulin Ad-
ministration
Subcutaneous injection and IV infusion. Inhalation:
Afrezza for mealtime insulin.
20. Insulin Dosing for Type
1 and Type 2
Type 1: Initial doses 0.5-0.6 units/kg/day. Type 2:
Initial doses 0.2-0.6 units/kg/day, adjusted based
on carb intake and activity.
21. 3 Dosing Schedules o Twice daily dosing
o Intensive basal/bolus strategy
o Continued subcutaneous insulin
22. Metformin Mechanism
of Action
o Inhibits glucose production in the liver
o Reduces glucose absorption in the gut
o Sensitizes insulin receptors in target tissues (fat
and skeletal muscle) to increase glucose uptake
and response to insulin
23. Metformin Side Effects
and BB Warning
o GI effects—diarrhea
o Lactic acidosis
2 / 20
Loading page 6...
Loading page 7...
4 more pages available. Scroll down to load them.
Preview Mode
Sign in to access the full document!
100%
Study Now!
XY-Copilot AI
Unlimited Access
Secure Payment
Instant Access
24/7 Support
Document Chat
Document Details
University
Chamberlain College of Nursing
Subject
Nursing